Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small‐cell carcinoma and squamous‐cell carcinomas
- 14 January 1985
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 35 (1), 11-17
- https://doi.org/10.1002/ijc.2910350104
Abstract
Murine monoclonal antibodies (MAbs) were generated against a human undifferentiated lung carcinoma cell line. The hybridoma designated LAM2 produced an IgM kappa MAb with reactivity to the cell membrane. Indirect immunofluorescence staining and radioimmunoassays showed LAM2 antibody to react preferentially with lung small‐cell carcinoma (SCC) cell lines and squamous‐cell carcinoma (SQC) cell lines. LAM2 antibody also stained primary cultures of normal bronchial epithelial cells, but was unreactive with human erythrocytes and nucleated marrow cells. Indirect immunofluorescent staining with LAM2 antibody was performed on frozen sections of human tumor tissues and normal tissues. LAM2 antibody stained all 8 SCC carcinomas. 4 of 5 SQC of the lung and head and neck region, and 2 of 4 lung large‐cell carcinomas. No staining was seen on lung adenocarcinomas, breast carcinomas, ovarian carcinomas, renal cell carcinomas, colon carcinomas, or mesotheliomas. Staining was present on sections of normal bronchus, but not on normal lung parenchyma, liver, kidney, adrenal or skin. While LAM2 antibody was highly reactive with all SCC examined, its antigenic determinant was not expressed in other cell lines and tumors of presumed neuroectodermal origin, including neuroblastoma, melanoma, and bronchial carcinoid. Radioimmunoprecipitation showed the antigen defined by LAM2 antibody to have two major bands of approximate molecular weights of 45,000 and 125,000. The selective reactivity of LAM2 antibody with SCC and SQC, but not with most other tumor tissues and normal tissues, makes it a good candidate for use in clinical diagnosis and possibly serotherapy.Keywords
This publication has 17 references indexed in Scilit:
- Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody.Journal of Clinical Oncology, 1985
- Analysis of cell surface proteins delineates a differentiation pathway linking endocrine and nonendocrine human lung cancers.Proceedings of the National Academy of Sciences, 1983
- Small cell carcinoma of the lungCancer Treatment Reviews, 1982
- A unique cell-surface protein phenotype distinguishes human small-cell from non-small-cell lung cancer.Proceedings of the National Academy of Sciences, 1982
- High Levels of Intracellular Bombesin Characterize Human Small-Cell Lung CarcinomaScience, 1981
- Expression of myeloid differentiation antigens on normal and malignant myeloid cells.JCI Insight, 1981
- Monoclonal antibodies that demonstrate specificity for several types of human lung cancer.Proceedings of the National Academy of Sciences, 1981
- Unpredictable course of small cell undifferentiated lung carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 1981
- The fine structure of large cell undifferentiated carcinoma of the lungHuman Pathology, 1978
- THE CYTOCHEMISTRY AND ULTRASTRUCTURE OF POLYPEPTIDE HORMONE-PRODUCING CELLS OF THE APUD SERIES AND THE EMBRYOLOGIC, PHYSIOLOGIC AND PATHOLOGIC IMPLICATIONS OF THE CONCEPTJournal of Histochemistry & Cytochemistry, 1969